Laidlaw Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,288
Closed -$596K 62
2024
Q4
$596K Buy
2,288
+10
+0.4% +$2.97K 0.26% 96
2024
Q3
$734K Sell
2,278
-130
-5% -$42.5K 0.36% 77
2024
Q2
$752K Buy
2,408
+364
+18% +$107K 0.41% 65
2024
Q1
$581K Sell
2,044
-3,911
-66% -$1.14M 0.32% 95
2023
Q4
$1.72M Sell
5,955
-198
-3% -$53.9K 0.62% 39
2023
Q3
$1.65M Sell
6,153
-391
-6% -$97.6K 0.55% 52
2023
Q2
$1.45M Sell
6,544
-759
-10% -$176K 0.28% 90
2023
Q1
$1.77M Sell
7,303
-2,791
-28% -$685K 0.36% 74
2022
Q4
$2.65M Buy
10,094
+2,906
+40% +$779K 0.57% 44
2022
Q3
$1.62M Sell
7,188
-458
-6% -$111K 0.38% 75
2022
Q2
$1.86M Sell
7,646
-68
-0.9% -$16.7K 0.38% 78
2022
Q1
$1.86M Sell
7,714
-482
-6% -$111K 0.31% 87
2021
Q4
$1.84M Buy
+8,196
New +$1.73M 0.29% 91
2021
Q3
Sell
-8,963
Closed -$2.19M 253
2021
Q2
$2.19M Buy
+8,963
New +$2.2M 0.56% 47
2021
Q1
Sell
-10,143
Closed -$2.33M 224
2020
Q4
$2.33M Buy
10,143
+2,529
+33% +$583K 0.49% 58
2020
Q3
$1.94M Sell
7,614
-65
-0.8% -$16.1K 0.86% 28
2020
Q2
$1.81M Sell
7,679
-144
-2% -$32.9K 0.95% 28
2020
Q1
$1.59M Sell
7,823
-429
-5% -$93.7K 1.04% 26
2019
Q4
$1.99M Buy
+8,252
New +$1.82M 1.26% 11

Other funds holding AMGN

Laidlaw Wealth Management's AMGN Position: Q1 2025 in Review

Laidlaw Wealth Management sold out of Amgen (AMGN) in Q1 2025, closing a stake of 2,288 shares — an estimated $596K sold.

Laidlaw Wealth Management first reported a position in AMGN in Q4 2019 and held it in 19 quarters. The position peaked at $2.65M in Q4 2022. 2,926 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Laidlaw Wealth Management reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Laidlaw Wealth Management sold 2,288 Amgen shares in Q1 2025, an estimated $596K.
  • Laidlaw Wealth Management first reported a position in Amgen in Q4 2019 and held it in 19 quarters.
  • Laidlaw Wealth Management's Amgen position peaked at $2.65M in Q4 2022.
  • 2,926 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Laidlaw Wealth Management's 13F filing for Q1 2025, filed 16 May 2025.